The rapidly spreading wildfires that have transformed much of Los Angeles County into a raging hellscape are not only upending the lives of tens of thousands of residents and business owners, but also stressing the region’s hospitals, health clinics, first responders, and nursing homes. At least one medical clinic burned down. Senior patients were evacuated…
The future of surgery will be shaped less by what our tools can do than by how well our systems help humans think when it matters most. The question is no longer whether the OR will evolve. It’s who will lead the transition The post The Digital Imperative: Why the Future of Surgery Will Be…
At MedCity News’ INVEST Digital Health conference, Sanford Health’s virtual care chief Dave Newman pointed out that in rural America, virtual care often determines whether patients receive treatment at all. He described how Sanford has expanded beyond video visits to include various other modalities like e-visit questionnaires, remote monitoring and even phone consults — saving…
This analysis examines the share of Medicare Advantage enrollees in contracts (which usually include multiple plans) that offered rewards or incentives for completing health risk assessments (HRAs) in 2023, as well as differences across Medicare Advantage insurers.
OK we are really back.! Following last weeks special with the Women Healthcare Leaders for Progress, the “regular” THCBGang is coming back for the Fall, mostly but not always at the 1pm PT 4pm ET timeslot on Thursdays. Joining Matthew Holt (@boltyboy) on #THCBGang on Friday October 4 at 1pm PST 4pm EST are futurist…
A 2024 Data Quality Framework (DQF) from the European Medicines Agency (EMA) aims to provide some guidance for drug manufacturers. Here is a summary of that document. Factors to be considered when evaluating RWD Key factors to be considered in the EMA’s DQF include: Reliability: Are the data correct?Extensiveness: Are the data enoughCoherence: Are the…
Cytokinetics drug Myqorzo won FDA approval for treating obstructive hypertrophic cardiomyopathy, or oHCM. Compared to Bristol Myers Squibb’s projected blockbuster drug Camzyos, the Cytokinetics daily pill has less restrictive safety and monitoring requirements, giving it a competitive advantage, according to analysts. The post FDA Approval Puts New Cytokinetics Heart Drug in Competition With Fast-Growing BMS…
AI can now flag where patients are getting stuck — from enrollment delays to dropped calls — while also enabling new, compliant ways to analyze these interactions at scale. But surfacing the issue is just the first step. The post Pharma Is Reclaiming Control Over Patient Experience. What Does It Mean For The Hub Model?…
Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S. Untangling the sprawling, global supply chain will be complicated and expensive, and could inadvertently compete with other administration goals regarding drug pricing and availability. The post The Myth of All-American Drugs and What Trump’s Tariffs Miss About…
For providers, the rules mean more control over monitoring and the chance to keep a larger share of reimbursement. For device companies, they create a chance to show measurable value and guide clinicians through a system that is shifting quickly. The post How New Medicare Rules Will Reshape Cardiac Monitoring and Remote Patient Care appeared…